Question 1

What is the catalog number for Fanetizole?

Accepted Answer

The catalog number for Fanetizole is M22251.

Question 2

What sizes are available for Fanetizole?

Accepted Answer

Fanetizole is available in the following size(s): 1 g, 500 mg, 5 mg, 1 mL x 10 mM in DMSO, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Question 3

How many pack sizes does Fanetizole come in?

Accepted Answer

Fanetizole is available in 9 different pack sizes.

Question 4

Is Fanetizole in stock?

Accepted Answer

Fanetizole is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Fanetizole used for?

Accepted Answer

Fanetizole shows immunoregulating activity.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 7

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 8

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Fanetizole

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Lentiviral human TM6SF1 shRNA (UAS) - Lentiviral human TM6SF1 shRNA (UAS, iRFP) plasmid

CDC37L1 Antibody - C-terminal region : FITC (ARP62437_P050-FITC)

Sugt1 ORF Vector (Rat) (pORF)

Phospho-PKR (Thr446) Blocking Peptide

Phospho-PKR (Thr446) Blocking Peptide

FBXO39 sgRNA CRISPR Lentivector (Human) (Target 2)